CAR-CLD18 T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAR-CLD18 T Cells, covering 2018-03-12 to 2018-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of CAR-CLD18 T Cells in Patients With Advanced Gastric Adenocarcinoma and Pancreatic Adenocarcinoma [NA]